Laetrile (Vitamin B17 or Amygdalin): Benefits, use

Amygdalin, also known as Vitamin B17, is a natural compound found in several plant species, including bitter almonds, apricot, peach, plum, and apple seeds. It is a glycoside compound made up of two molecules of glucose, one molecule of benzaldehyde, and one molecule of hydrocyanic acid (HCN). Its molecular formula is C20H27NO11 and its molecular weight is 457.4 g/mol.

The extraction process of Amygdalin involves crushing the seeds of the plants that contain it and then using solvents to extract the compound. The pure Amygdalin is then isolated through various purification steps, including filtration, centrifugation, and crystallization. The final product obtained is a white crystalline powder that is odorless and almost tasteless.

Amygdalin has been traditionally used as a treatment for cancer, and it is believed to possess Anti-Cancer properties. It is also said to have analgesic, antipyretic, and Anti-Inflammatory effects. The compound is thought to work by breaking down into glucose, hydrogen cyanide, and benzaldehyde in the body. Hydrogen cyanide is believed to be toxic to cancer cells, while benzaldehyde has anti-inflammatory properties.

Research on the efficacy of Amygdalin in cancer treatment is still ongoing, and there is controversy over its use. Some studies have found that the compound may have potential in treating some types of cancer, while others have found that it may be harmful to health. The use of Amygdalin as a cancer treatment is not approved by the US Food and Drug Administration (FDA), and it is classified as a "quack" remedy in many countries.

In conclusion, Amygdalin or Vitamin B17 is a glycoside compound found in several plant species. Its potential use in cancer treatment is still controversial, and more research is needed to establish its safety and efficacy. The extraction process of Amygdalin involves using solvents to extract the compound from plant seeds. While some people claim that it has medicinal properties, it is important to note that its use is not approved by regulatory bodies and may be harmful. Further studies are required to determine whether Amygdalin can be considered a useful therapeutic agent.